Insider · CIK 0001734755

VASCONCELLES MICHAEL

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001734755

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-04-23	DAWNDay One Biopharmaceuticals, Inc.D Disposition to Issuer	Head of Research and Dev.	DDisposition to Issuer	−4,397 sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Head of Research and Dev.	DDisposition to Issuer	−346K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Head of Research and Dev.	DDisposition to Issuer	−171K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Head of Research and Dev.	DDisposition to Issuer	−226K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Head of Research and Dev.	DDisposition to Issuer	−107K sh	—	—	0
2026-02-17	DAWNDay One Biopharmaceuticals, Inc.S Sale	Head of Research and Dev.	SSale	−2,728 sh	$11.60	−$31.6K	4,397
2026-02-15	DAWNDay One Biopharmaceuticals, Inc.M Exercise/Conversion	Head of Research and Dev.	MExercise/Conversion	+7,125 sh	—	—	7,125
2026-02-15	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)M Exercise/Conversion	Head of Research and Dev.	MExercise/Conversion	−7,125 sh	—	—	106,875
2026-01-30	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Head of Research and Dev.	AAward	+171K sh	—	—	171,000
2026-01-30	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock UnitsA Award	Head of Research and Dev.	AAward	+114K sh	—	—	114,000
2025-06-16	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Head of Research and Dev.	AAward	+346K sh	—	—	346,000
2025-06-16	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)A Award	Head of Research and Dev.	AAward	+226K sh	—	—	226,000
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2024-09-13	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+52K sh	—	—	52,000
2024-09-13	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+17.3K sh	—	—	17,333
2024-02-12	ImmunoGen, Inc.D Disposition to Issuer	EVP R&D & MEDICAL AFFAIRS	DDisposition to Issuer	−1,327 sh	—	—	0
2024-02-12	ImmunoGen, Inc.Stock Option (Right to Buy)D Disposition to Issuer	EVP R&D & MEDICAL AFFAIRS	DDisposition to Issuer	−960K sh	—	—	0
2024-02-12	ImmunoGen, Inc.Restricted Stock UnitD Disposition to Issuer	EVP R&D & MEDICAL AFFAIRS	DDisposition to Issuer	−50.5K sh	—	—	0
2024-02-01	ImmunoGen, Inc.Restricted Stock UnitA Award	EVP R&D & MEDICAL AFFAIRS	AAward	+50.5K sh	—	—	50,515
2023-12-29	ImmunoGen, Inc.A Award	EVP R&D & MEDICAL AFFAIRS	AAward	+1,327 sh	$16.01	+$21.2K	1,327
2022-12-29	ImmunoGen, Inc.Stock Option (Right to Buy)A Award	EVP R&D & MEDICAL AFFAIRS	AAward	+960K sh	—	—	960,000
2022-08-15	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-03-01	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+61.9K sh	—	—	61,900

Recent filings

Accepted (ET)
Jun 44
VASCONCELLES MICHAEL0001193125-26-257902
SEC(opens sec.gov)
Apr 234
VASCONCELLES MICHAEL0001734755-26-000005
SEC(opens sec.gov)
Feb 184
VASCONCELLES MICHAEL0001734755-26-000004
SEC(opens sec.gov)
Jan 304
VASCONCELLES MICHAEL0001734755-26-000002
SEC(opens sec.gov)
Jun 184
VASCONCELLES MICHAEL0001415889-25-017742
SEC(opens sec.gov)
Jun 64
VASCONCELLES MICHAEL0000950170-25-083037
SEC(opens sec.gov)
Sep 174
VASCONCELLES MICHAEL0000950170-24-107272
SEC(opens sec.gov)
Feb 124
VASCONCELLES MICHAEL0001104659-24-014692
SEC(opens sec.gov)
Feb 54
VASCONCELLES MICHAEL0001415889-24-002764
SEC(opens sec.gov)

Companies

Address

C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500

SAN DIEGO, CA, 92121